Refractory nephrotic syndrome continues to be a therapeutic challenge despite advances in immunosuppression and blockade of the renin–angiotensin–aldosterone cascade. Adrenocorticotropic hormone (ACTH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback